Farallon Capital filed Amendment No. 4 reporting its beneficial ownership in Tango Therapeutics, Inc. The filing states the Farallon Funds hold an aggregate of 9,097,411 Shares and 2,159,792 Pre-Funded Common Stock Purchase Warrants, each exercisable for one Share. The filing says the Warrants are subject to a Beneficial Ownership Limitation of 9.99% and that the Reporting Persons have assumed all Warrants are exercisable within 60 days for the purpose of computing beneficial ownership. The filing lists the Farallon funds, affiliated general partners, and individual Farallon managers and provides per-entity ownership counts and shared voting/dispositive power figures.
Positive
None.
Negative
None.
Insights
Farallon discloses concentrated, exercisable positions in Tango.
The filing reports the Farallon Funds collectively hold 9,097,411 Shares and 2,159,792 Warrants, with the Warrants treated as exercisable within 60 days for reporting. The report explicitly cites a 9.99% Beneficial Ownership Limitation that constrains potential exercises.
Future filings may show exercises or dispositions; cash‑flow treatment is not stated in this excerpt and subsequent reports would clarify changes in ownership or voting power.
Group structure and attribution are detailed; multiple entities and individuals are named.
The schedule lists the Farallon Funds, their general partners, and 15 individual reporting persons, and it describes how general partners and managing members may be deemed beneficial owners while including disclaimers of ownership. The filing is an amendment to prior Schedule 13G/A filings and attaches a joint acquisition statement reference.
Material governance implications depend on any future changes in shared voting or disposition powers disclosed in later filings; this amendment documents current holdings and internal attribution structure.
Key Figures
Shares held:9,097,411 SharesPre-Funded Warrants:2,159,792 WarrantsBeneficial Ownership Limit:9.99%+3 more
6 metrics
Shares held9,097,411 Sharesaggregate held by the Farallon Funds
Pre-Funded Warrants2,159,792 Warrantseach exercisable for one Share; treated as exercisable within 60 days for reporting
Beneficial Ownership Limit9.99%exercise cap specified in the Warrants
Assumed exercisability period60 daysassumption used by Reporting Persons to compute beneficial ownership
Example entity holding10,964,477 SharesFarallon Partners, L.L.C. shared voting/dispositive power figure shown on cover rows
Example fund holding5,008,902 SharesFarallon Healthcare Partners Master, L.P. shared voting/dispositive power figure shown on cover rows
Key Terms
Pre-Funded Common Stock Purchase Warrant, Beneficial Ownership Limitation, Schedule 13G/A
3 terms
Pre-Funded Common Stock Purchase Warrantfinancial
"2,159,792 Pre-Funded Common Stock Purchase Warrants (the "Warrants")"
Beneficial Ownership Limitationregulatory
"Warrants may not be exercised to the extent that ... more than 9.99% of the Shares"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Schedule 13G/Aregulatory
"This Amendment No. 4 to (this "Amendment") is filed ..."
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 4)
Tango Therapeutics, Inc.
(Name of Issuer)
Common stock, par value $0.001 per share (the "Shares")
(Title of Class of Securities)
87583X109
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Capital Partners, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CALIFORNIA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,055,717.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,055,717.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,055,717.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.7 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Capital Institutional Partners, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CALIFORNIA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,470,591.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,470,591.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,470,591.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Capital Institutional Partners II, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CALIFORNIA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
290,563.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
290,563.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
290,563.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.2 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Capital Institutional Partners III, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
226,033.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
226,033.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
226,033.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.2 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Four Crossings Institutional Partners V, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
260,503.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
260,503.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
260,503.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.2 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Capital Offshore Investors II, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
2,488,434.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
2,488,434.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
2,488,434.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.7 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Capital (AM) Investors, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
163,734.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
163,734.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
163,734.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.1 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Capital F5 Master I, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
292,726.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
292,726.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
292,726.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.2 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Healthcare Partners Master, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,008,902.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,008,902.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,008,902.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.5 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Partners, L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
10,964,477.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
10,964,477.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
10,964,477.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.6 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Institutional (GP) V, L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
260,503.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
260,503.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
260,503.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.2 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon F5 (GP), L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
292,726.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
292,726.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
292,726.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.2 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Farallon Healthcare Partners (GP), L.L.C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,008,902.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,008,902.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,008,902.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.5 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Dapice Joshua J.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Dreyfuss, Philip D.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Dunn Hannah E.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Gehani, Varun N.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Giauque, Nicolas
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
FRANCE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Husen, Avner A.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Kim, David T.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Linn, Michael G.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Luo Patrick (Cheng)
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CHINA
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Roberts, Jr., Thomas G.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Saito Edric C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Short Daniel S.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Spokes, Andrew J. M.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED KINGDOM
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Warren, John R.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
87583X109
1
Names of Reporting Persons
Wehrly, Mark C.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
11,257,203.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
11,257,203.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
11,257,203.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.8 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Tango Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
201 Brookline Ave., Suite 901, Boston, Massachusetts, 02215
Item 2.
(a)
Name of person filing:
This Amendment No. 4 to Schedule 13G (this "Amendment") is filed by the entities and persons listed below, all of whom together are referred to herein as the "Reporting Persons."
(i) Farallon Capital Partners, L.P., a California limited partnership ("FCP"), with respect to the Shares held by it and the Shares that it currently has the right to acquire upon the exercise of Warrants (as defined in Item 4);
(ii) Farallon Capital Institutional Partners, L.P., a California limited partnership ("FCIP"), with respect to the Shares held by it and the Shares that it currently has the right to acquire upon the exercise of Warrants;
(iii) Farallon Capital Institutional Partners II, L.P., a California limited partnership ("FCIP II"), with respect to the Shares held by it and the Shares that it currently has the right to acquire upon the exercise of Warrants;
(iv) Farallon Capital Institutional Partners III, L.P., a Delaware limited partnership ("FCIP III"), with respect to the Shares held by it and the Shares that it currently has the right to acquire upon the exercise of Warrants;
(v) Four Crossings Institutional Partners V, L.P., a Delaware limited partnership ("FCIP V"), with respect to the Shares held by it and the Shares that it currently has the right to acquire upon the exercise of Warrants;
(vi) Farallon Capital Offshore Investors II, L.P., a Cayman Islands exempted limited partnership ("FCOI II"), with respect to the Shares held by it and the Shares that it currently has the right to acquire upon the exercise of Warrants;
(vii) Farallon Capital (AM) Investors, L.P., a Delaware limited partnership ("FCAMI"), with respect to the Shares held by it and the Shares that it currently has the right to acquire upon the exercise of Warrants;
(viii) Farallon Capital F5 Master I, L.P., a Cayman Islands exempted limited partnership ("F5MI"), with respect to the Shares held by it and the Shares that it currently has the right to acquire upon the exercise of Warrants; and
(ix) Farallon Healthcare Partners Master, L.P., a Cayman Islands exempted limited partnership ("FHPM"), with respect to the Shares held by it.
FCP, FCIP, FCIP II, FCIP III, FCIP V, FCOI II, FCAMI, F5MI and FHPM are together referred to herein as the "Farallon Funds."
(x) Farallon Partners, L.L.C., a Delaware limited liability company (the "Farallon General Partner"), which is the general partner of each of FCP, FCIP, FCIP II, FCIP III, FCOI II and FCAMI and the sole member of each of the FCIP V General Partner (as defined below) and the FHPM General Partner (as defined below), with respect to the Shares held by each of the Farallon Funds other than F5MI and the Shares that each of the Farallon Funds other than F5MI currently has the right to acquire upon the exercise of Warrants.
(xi) Farallon Institutional (GP) V, L.L.C., a Delaware limited liability company (the "FCIP V General Partner"), which is the general partner of FCIP V, with respect to the Shares held by FCIP V and the Shares that FCIP V currently has the right to acquire upon the exercise of Warrants.
(xii) Farallon F5 (GP), L.L.C., a Delaware limited liability company (the "F5MI General Partner"), which is the general partner of F5MI, with respect to the Shares held by F5MI and the Shares that F5MI currently has the right to acquire upon the exercise of Warrants.
(xiii) Farallon Healthcare Partners (GP), L.L.C., a Delaware limited liability company (the "FHPM General Partner"), which is the general partner of FHPM, with respect to the Shares held by FHPM.
(xiv) The following persons, each of whom is a managing member or senior managing member, as the case may be, of the Farallon General Partner and a manager or senior manager, as the case may be, of the FCIP V General Partner, the F5MI General Partner and the FHPM General Partner, with respect to the Shares held by the Farallon Funds and the Shares that the Farallon Funds currently have the right to acquire upon the exercise of Warrants: Joshua J. Dapice ("Dapice"); Philip D. Dreyfuss ("Dreyfuss"); Hannah E. Dunn ("Dunn"); Varun N. Gehani ("Gehani"); Nicolas Giauque ("Giauque"); Avner A. Husen ("Husen"); David T. Kim ("Kim"); Michael G. Linn ("Linn"); Patrick (Cheng) Luo ("Luo"); Thomas G. Roberts, Jr. ("Roberts"); Edric C. Saito ("Saito"); Daniel S. Short ("Short"); Andrew J. M. Spokes ("Spokes"); John R. Warren ("Warren"); and Mark C. Wehrly ("Wehrly").
Dapice, Dreyfuss, Dunn, Gehani, Giauque, Husen, Kim, Linn, Luo, Roberts, Saito, Short, Spokes, Warren and Wehrly are together referred to herein as the "Farallon Individual Reporting Persons."
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is c/o Farallon Capital Management, L.L.C., One Maritime Plaza, Suite 2100, San Francisco, California 94111.
(c)
Citizenship:
The citizenship of each of the Farallon Funds, the Farallon General Partner, the FCIP V General Partner, the F5MI General Partner and the FHPM General Partner is set forth above. Each of the Farallon Individual Reporting Persons, other than Giauque, Luo and Spokes, is a citizen of the United States. Giauque is a citizen of France. Luo is a citizen of China. Spokes is a citizen of the United Kingdom.
(d)
Title of class of securities:
Common stock, par value $0.001 per share (the "Shares")
(e)
CUSIP No.:
87583X109
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person.
As of the date requiring the filing of this report, the Farallon Funds hold an aggregate of: (i) 9,097,411 Shares; and (ii) 2,159,792 Pre-Funded Common Stock Purchase Warrants (the "Warrants"), each of which is exercisable, subject to the Beneficial Ownership Limitation (as defined below), to purchase one Share.
The terms of the Warrants provide that Warrants may not be exercised to the extent that, after giving effect to such exercise, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 9.99% of the Shares then issued and outstanding (the "Beneficial Ownership Limitation"). As of the date requiring the filing of this report, the Beneficial Ownership Limitation does not prevent the Farallon Funds from exercising any Warrants. Accordingly, in providing the beneficial ownership information set forth herein, the Reporting Persons have assumed that all of the aggregate 2,159,792 Warrants held by the Farallon Funds are exercisable within 60 days of the date hereof and therefore confer beneficial ownership of the underlying Shares.
The Shares and Warrants reported hereby for the Farallon Funds are held directly by the Farallon Funds. The Farallon General Partner, as the general partner of FCP, FCIP, FCIP II, FCIP III, FCOI II and FCAMI and the sole member of the FCIP V General Partner and the FHPM General Partner, may be deemed to be a beneficial owner of all such Shares held by the Farallon Funds other than F5MI and the Shares that the Farallon Funds other than F5MI have the right to acquire upon the exercise of Warrants. The FCIP V General Partner, as the general partner of FCIP V, may be deemed to be a beneficial owner of all such Shares held by FCIP V and the Shares that FCIP V has the right to acquire upon the exercise of Warrants. The F5MI General Partner, as the general partner of F5MI, may be deemed to be a beneficial owner of all such Shares held by F5MI and the Shares that F5MI has the right to acquire upon the exercise of Warrants. The FHPM General Partner, as the general partner of FHPM, may be deemed to be a beneficial owner of all such Shares held by FHPM. Each of the Farallon Individual Reporting Persons, as a managing member or senior managing member, as the case may be, of the Farallon General Partner and a manager or senior manager, as the case may be, of the FCIP V General Partner, the F5MI General Partner and the FHPM General Partner, in each case with the power to exercise investment discretion, may be deemed to be a beneficial owner of all such Shares held by the Farallon Funds and the Shares that the Farallon Funds have the right to acquire upon the exercise of Warrants. Each of the Farallon General Partner, the FCIP V General Partner, the F5MI General Partner, the FHPM General Partner and the Farallon Individual Reporting Persons hereby disclaims any beneficial ownership of any such Shares.
(b)
Percent of class:
The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person.
(ii) Shared power to vote or to direct the vote:
The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Items 4(a) - (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
The Reporting Persons are filing this Schedule 13G pursuant to Section 240.13d-1(c). The Reporting Persons neither disclaim nor affirm the existence of a group among them. Each Reporting Person is a beneficial owner only of the securities reported by it on its cover page.
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Farallon Capital Partners, L.P.
Signature:
/s/ Hannah E. Dunn
Name/Title:
Hannah E. Dunn, Managing Member of its General Partner
Date:
05/11/2026
Farallon Capital Institutional Partners, L.P.
Signature:
/s/ Hannah E. Dunn
Name/Title:
Hannah E. Dunn, Managing Member of its General Partner
Date:
05/11/2026
Farallon Capital Institutional Partners II, L.P.
Signature:
/s/ Hannah E. Dunn
Name/Title:
Hannah E. Dunn, Managing Member of its General Partner
Date:
05/11/2026
Farallon Capital Institutional Partners III, L.P.
Signature:
/s/ Hannah E. Dunn
Name/Title:
Hannah E. Dunn, Managing Member of its General Partner
Date:
05/11/2026
Four Crossings Institutional Partners V, L.P.
Signature:
/s/ Hannah E. Dunn
Name/Title:
Hannah E. Dunn, Manager of its General Partner
Date:
05/11/2026
Farallon Capital Offshore Investors II, L.P.
Signature:
/s/ Hannah E. Dunn
Name/Title:
Hannah E. Dunn, Managing Member of its General Partner
Date:
05/11/2026
Farallon Capital (AM) Investors, L.P.
Signature:
/s/ Hannah E. Dunn
Name/Title:
Hannah E. Dunn, Managing Member of its General Partner
How many Tango Therapeutics (TNGX) shares does Farallon report owning?
Farallon reports holding 9,097,411 Shares of Tango Therapeutics. The filing states this aggregate figure for the Farallon Funds as the basis for the reported beneficial ownership positions.
How many warrants does Farallon report and can they be exercised?
Farallon reports 2,159,792 Pre-Funded Common Stock Purchase Warrants, each exercisable for one Share. The filing treats these Warrants as exercisable within 60 days for reporting calculations.
What is the Beneficial Ownership Limitation mentioned in the filing?
The Warrants include a Beneficial Ownership Limitation of 9.99%, which prevents exercise that would cause beneficial ownership to exceed that percentage, as described in the filing.
Which Farallon entities and people are named as reporting persons on the filing?
The filing names multiple Farallon Funds (e.g., FCP, FCIP, FHPM), related general partners, and 15 individual Farallon managers including Joshua J. Dapice and Hannah E. Dunn, among others, as Reporting Persons.
Does the filing state who receives cash if warrants are exercised?
The filing does not state the cash‑flow recipients for any exercise proceeds in the provided excerpt. It describes ownership and exercisability assumptions but not proceeds allocation.
